NASDAQ · TSNIX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:07 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
T. Rowe Price Science And Technology Fund’s quoted price sits in the upper half of its reported 52-week range, 19.13% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
T. Rowe Price Science And Technology Fund’s forward annual dividend is $6.74 per share, paid annual. The forward yield is 9.94% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund typically commits a minimum of 80% of its total assets, including any capital acquired through borrowing for investment, to the common stocks of enterprises positioned to gain from the progress and utilization of science and technology. Although its portfolio predominantly consists of U.S. common stocks, it retains the flexibility to invest in foreign equities, such as those from emerging markets, aligning with its overall investment mandate. This fund maintains a non-diversified investment approach.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:33 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$50.21+$0.76 (+1.54%)
Victory Sycamore Established Value Fund Class C’s quoted price sits in the upper half of its reported 52-week range, 0.61% below the high.
$46.69-$0.02 (-0.04%)
FPA Crescent Fund’s quoted price sits in the upper half of its reported 52-week range, 1.41% below the high.
$27.44-$0.09 (-0.33%)
MFS Research International R2’s quoted price sits in the upper half of its reported 52-week range, 4.62% below the high.
$22.95$0.00 (0.0%)
BlackRock LifePath Index 2035 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.84% below the high.
$25.55-$0.02 (-0.08%)
T. Rowe Price Retirement 2055 Fund’s quoted price sits in the upper half of its reported 52-week range, 2.59% below the high.
$65.54-$0.32 (-0.49%)
Invesco Main Street Fund’s quoted price sits in the upper half of its reported 52-week range, 1.41% below the high.
$60.51+$0.01 (+0.02%)
Hartford Core Equity Fund’s quoted price sits in the upper half of its reported 52-week range, 1.63% below the high.
$41.39-$0.21 (-0.5%)
Principal Blue Chip Fund’s quoted price sits in the lower half of its reported 52-week range, 19.69% below the high.
